NASDAQ:MATK
$31.49
- 0.01
Feb 25, 2011
4:00 PM ET
Martek Biosciences Corporation
Investors
Home
About Martek
Healthcare Professionals
Investors
Press Releases
Events & Presentations
Management
Financial Information
SEC Filings
Quarterly Results
Annual Reports & Proxy
Investor FAQs
Products & Services
Home
Investors
Annual Report and Proxy
Annual Report and Proxy
2009 Annual Report
2010 Proxy Statement
View Archived Reports
Document
Type
Size
2009 Form 10-K
N/A
Annual Report 2008
1.2 MB
2009 Proxy Statement
180.6 KB
Annual Report 2007
1.7 MB
Annual Report 2006
4.1 MB
Annual Report 2005
1.5 MB
Annual Report 2004
2.5 MB
If you are
not
a shareowner - you may request printed copies here:
Investor Kit